ABCA12 p.Ser387Asn
[switch to full view]Comments [show]
None has been submitted yet.
PMID: 21695020
[PubMed]
Akiyama M et al: "The roles of ABCA12 in keratinocyte differentiation and lipid barrier formation in the epidermis."
No.
Sentence
Comment
36
One patient was homozygous for the splice site mutation c.3295-2A>G4 and another was compound heterozygous for p.Ser387Asn and p.Thr1387del.29 Only one heterozygous mutation, p.Ile1494Thr, was identified in the other patient.30 Cultured keratinocytes from all three patients showed apparently disturbed glucosylceramide transport, although this assay is not quantitative.
X
ABCA12 p.Ser387Asn 21695020:36:113
status: NEW37 One patient was homozygous for the splice site mutation c.3295-2A>G4 and another was compound heterozygous for p.Ser387Asn and p.Thr1387del.29 Only one heterozygous mutation, p.Ile1494Thr, was identified in the other patient.30 Cultured keratinocytes from all three patients showed apparently disturbed glucosylceramide transport, although this assay is not quantitative.
X
ABCA12 p.Ser387Asn 21695020:37:113
status: NEW
PMID: 20672373
[PubMed]
Akiyama M et al: "ABCA12 mutations and autosomal recessive congenital ichthyosis: a review of genotype/phenotype correlations and of pathogenetic concepts."
No.
Sentence
Comment
106
One patient was a homozygote for a splice site mutation c.3295À2A4G [Akiyama et al., 2005] and another patient was a compound heterozygote for p.Ser387Asn and p.Thr1387del [Akiyama et al., 2006a].
X
ABCA12 p.Ser387Asn 20672373:106:150
status: NEW
PMID: 17591952
[PubMed]
Yamanaka Y et al: "Expression of the keratinocyte lipid transporter ABCA12 in developing and reconstituted human epidermis."
No.
Sentence
Comment
51
One patient harbored a homozygous splice site mutation c.3295-2AϾG and the other harbored heterozygous mutations: p.Ser387Asn and c.4158_4160del (p.Thr1387del) as previously reported.36 In detail, patients` keratinocytes were isolated from lesional epidermis after separation from the dermis by overnight treatment of dispase I (Godoshusei, Chiba, Japan).
X
ABCA12 p.Ser387Asn 17591952:51:122
status: NEW61 Thus, with the same methods, we reconstituted HI lesions using keratinocytes from another patient with HI who had heterozygous mutations affecting both ABCA12 alleles, p.Ser387Asn and c.4158_4160del (p.Thr1387del) (see Ref. 37 for further detailed analysis of the reconstituted lesions).
X
ABCA12 p.Ser387Asn 17591952:61:170
status: NEW128 We regenerated HI skin lesions using cultured keratinocytes harboring ABCA12 mutations p.Ser387Asn and c.4158_4160del (p.Thr1387del) and normal human fibroblasts.
X
ABCA12 p.Ser387Asn 17591952:128:89
status: NEW60 Thus, with the same methods, we reconstituted HI lesions using keratinocytes from another patient with HI who had heterozygous mutations affecting both ABCA12 alleles, p.Ser387Asn and c.4158_4160del (p.Thr1387del) (see Ref. 37 for further detailed analysis of the reconstituted lesions).
X
ABCA12 p.Ser387Asn 17591952:60:170
status: NEW127 We regenerated HI skin lesions using cultured keratinocytes harboring ABCA12 mutations p.Ser387Asn and c.4158_4160del (p.Thr1387del) and normal human fibroblasts.
X
ABCA12 p.Ser387Asn 17591952:127:89
status: NEW
PMID: 16675967
[PubMed]
Akiyama M et al: "Compound heterozygous mutations including a de novo missense mutation in ABCA12 led to a case of harlequin ichthyosis with moderate clinical severity."
No.
Sentence
Comment
4
This patient with moderate clinical severity was compound heterozygous for a novel de novo missense mutation 1160G4A (S387N) in exon 10 and a maternal deletion mutation 4158_4160delTAC (T1387del) in exon 28 of ABCA12.
X
ABCA12 p.Ser387Asn 16675967:4:118
status: NEW6 Conversely, the residue 387 is located outside the known active sites of ABCA12 and S387N is predicted not to lead to a serious functional deficiency in ABCA12.
X
ABCA12 p.Ser387Asn 16675967:6:84
status: NEW16 In the study of this case, we have found a compound heterozygous ABCA12 combination of mutations, a novel de novo missense mutation, S387N, in exon 10 and a maternal deletion mutation T1387del in exon 28 in a newborn HI baby.
X
ABCA12 p.Ser387Asn 16675967:16:133
status: NEW20 In addition, the novel mutation S387N was the first reported de novo mutation in ABCA12.
X
ABCA12 p.Ser387Asn 16675967:20:32
status: NEW33 The mutation 1160G4A transition was a novel missense mutation that changed a serine residue of codon 387 to an asparagine residue (S387N).
X
ABCA12 p.Ser387Asn 16675967:33:131
status: NEW34 This missense mutation S387N was not found in either in the parent`s (father or mother), although the patient`s mother was heterozygous for the deletion mutation 4158_4160delTAC (Figure 2).
X
ABCA12 p.Ser387Asn 16675967:34:23
status: NEW35 Thus, the missense mutation S387N was thought to be a de novo mutation and the deletion mutation was a maternal mutation.
X
ABCA12 p.Ser387Asn 16675967:35:28
status: NEW52 1160G>A (S387N) 4158_4160delTAC (T1387del) (maternal) a b Patient Control Patient Control Father Mother Father Mother A A A A A A A A A A AA A A A A AA AA A A A A A A A A AA A A A AC C C C C C C CC C C CC C C CCC C C CC C C C CCCT T TTN N N N N N N N N T TTT T T TT T T T T T TT T T T T TTT G GGGGGGGGGGG GG GG G GG G G G G (de novo) TAC TAC Figure 2.
X
ABCA12 p.Ser387Asn 16675967:52:9
status: NEW54 (a) Direct sequencing revealed a heterozygous 1160G4A transition (a missense mutation S387N) in exon 10 of ABCA12 of the patient, but not in his parents or normal control samples.
X
ABCA12 p.Ser387Asn 16675967:54:86
status: NEW96 The novel de novo mutation S387N in the present patient is located outside all of the known ABCA12 active transporter sites, within the cytoplasmic domain at N-terminus of ABCA12 polypeptide (Figure 6).
X
ABCA12 p.Ser387Asn 16675967:96:27
status: NEW98 Thus, one would predict the de novo missense mutation S387N not to lead to a serious ABCA12 functional loss.
X
ABCA12 p.Ser387Asn 16675967:98:54
status: NEW111 The present novel missense mutation S387N in our case was the first de novo mutation reported in ABCA12.
X
ABCA12 p.Ser387Asn 16675967:111:36
status: NEW118 Briefly, genomic DNA isolated from peripheral blood was subjected to PCR amplification, followed by direct automated NH2 (de novo) (Maternal) T1387del (exon 28) S387N (exon 10) Cytoplasmicside B A COOH ATP-binding cassettes A B Walker A and B motifs Active transport signature Membrane Figure 6.
X
ABCA12 p.Ser387Asn 16675967:118:161
status: NEW121 Note that the de novo missense mutation S387N is located in the intracytoplasmic region between the N-terminus and the first transmembrane domain, not in any active sites, and the other, deletion mutation T1387del is within the first ATP-binding cassette, which is thought to be important for ABCA12 lipid transporter activity.
X
ABCA12 p.Ser387Asn 16675967:121:40
status: NEW
PMID: 23954554
[PubMed]
Akiyama M et al: "The roles of ABCA12 in epidermal lipid barrier formation and keratinocyte differentiation."
No.
Sentence
Comment
83
One patient was homozygous for the splice-site mutation c.3295-2ANG [4], and another was compound heterozygous for p.Ser387Asn and p.Thr1387del [38].
X
ABCA12 p.Ser387Asn 23954554:83:117
status: NEW